PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma

Guardado en:

Detalles Bibliográficos
Autores principales:	Michael B. Atkins, Suthee Rapisuwon, Arash Radfar, Kellie Gardner, Neil J. Shah, Geoffrey T. Gibney, Jacob Zaemes, Shelly Shand, David Swoboda, Vesna Petronic-Rosic, Michael J. Reilly, Waddah B. Al-Refaie
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/da787bd08d4c48ef8ac5864ccea25a5d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:da787bd08d4c48ef8ac5864ccea25a5d
record_format	dspace
spelling	oai:doaj.org-article:da787bd08d4c48ef8ac5864ccea25a5d2021-11-22T07:00:07ZPET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma10.1136/jitc-2021-0029552051-1426https://doaj.org/article/da787bd08d4c48ef8ac5864ccea25a5d2021-10-01T00:00:00Zhttps://jitc.bmj.com/content/9/10/e002955.fullhttps://doaj.org/toc/2051-1426Michael B. AtkinsSuthee RapisuwonArash RadfarKellie GardnerNeil J. ShahGeoffrey T. GibneyJacob ZaemesShelly ShandDavid SwobodaVesna Petronic-RosicMichael J. ReillyWaddah B. Al-RefaieBMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Michael B. Atkins Suthee Rapisuwon Arash Radfar Kellie Gardner Neil J. Shah Geoffrey T. Gibney Jacob Zaemes Shelly Shand David Swoboda Vesna Petronic-Rosic Michael J. Reilly Waddah B. Al-Refaie PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma
format	article
author	Michael B. Atkins Suthee Rapisuwon Arash Radfar Kellie Gardner Neil J. Shah Geoffrey T. Gibney Jacob Zaemes Shelly Shand David Swoboda Vesna Petronic-Rosic Michael J. Reilly Waddah B. Al-Refaie
author_facet	Michael B. Atkins Suthee Rapisuwon Arash Radfar Kellie Gardner Neil J. Shah Geoffrey T. Gibney Jacob Zaemes Shelly Shand David Swoboda Vesna Petronic-Rosic Michael J. Reilly Waddah B. Al-Refaie
author_sort	Michael B. Atkins
title	PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma
title_short	PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma
title_full	PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma
title_fullStr	PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma
title_full_unstemmed	PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma
title_sort	pet/ct scan and biopsy-driven approach for safe anti-pd-1 therapy discontinuation in patients with advanced melanoma
publisher	BMJ Publishing Group
publishDate	2021
url	https://doaj.org/article/da787bd08d4c48ef8ac5864ccea25a5d
work_keys_str_mv	AT michaelbatkins petctscanandbiopsydrivenapproachforsafeantipd1therapydiscontinuationinpatientswithadvancedmelanoma AT sutheerapisuwon petctscanandbiopsydrivenapproachforsafeantipd1therapydiscontinuationinpatientswithadvancedmelanoma AT arashradfar petctscanandbiopsydrivenapproachforsafeantipd1therapydiscontinuationinpatientswithadvancedmelanoma AT kelliegardner petctscanandbiopsydrivenapproachforsafeantipd1therapydiscontinuationinpatientswithadvancedmelanoma AT neiljshah petctscanandbiopsydrivenapproachforsafeantipd1therapydiscontinuationinpatientswithadvancedmelanoma AT geoffreytgibney petctscanandbiopsydrivenapproachforsafeantipd1therapydiscontinuationinpatientswithadvancedmelanoma AT jacobzaemes petctscanandbiopsydrivenapproachforsafeantipd1therapydiscontinuationinpatientswithadvancedmelanoma AT shellyshand petctscanandbiopsydrivenapproachforsafeantipd1therapydiscontinuationinpatientswithadvancedmelanoma AT davidswoboda petctscanandbiopsydrivenapproachforsafeantipd1therapydiscontinuationinpatientswithadvancedmelanoma AT vesnapetronicrosic petctscanandbiopsydrivenapproachforsafeantipd1therapydiscontinuationinpatientswithadvancedmelanoma AT michaeljreilly petctscanandbiopsydrivenapproachforsafeantipd1therapydiscontinuationinpatientswithadvancedmelanoma AT waddahbalrefaie petctscanandbiopsydrivenapproachforsafeantipd1therapydiscontinuationinpatientswithadvancedmelanoma
_version_	1718418131767001088

PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma

Ejemplares similares